Japan’s Taiho Pharmaceutical to acquire Swiss Biotech Araris for $1.14 billion

Swiss oncology biotech firm Araris Biotech AG has entered into an acquisition agreement with Taiho Pharmaceutical Co., Ltd, marking a significant milestone for the advanced therapies industry, 4BIO Capital announced Monday. The Japanese company will pay $400 million upfront, with additional milestone payments potentially bringing the total to $1.14 billion. The acquisition is set to close in…

BSF and Amelie Pichard to create first lab-grown leather fashion accessories

LONDON: BSF, a biotech company that owns tissue engineering firms 3DBT and Kerato, has signed a memorandum of understanding with Maison Amelie Pichard, a fashion company that uses eco-friendly materials, to develop and sell fashion accessories that incorporate lab-grown leather. This is the first time that real lab-grown leather, which mimics the structure of traditional…

Booster launches investment fund to support early start tech and science

WELLINGTON, NEW ZEALAND: KiwiSaver provider, Booster Investment Management Limited, is kicking off the first NZX listing of 2022, with the launch of its new retail investment fund, the Booster Innovation Fund (BIF). The investment fund is the very first of its kind listed on the NZX (on 2 March), providing Kiwis with direct access to…

Abcam Plc

Abcam Plc is a producer, distributor and seller of protein research tools. The company was founded in 1998 by Jonathan Milner with co-founders professor Tony Kouzarides and David Cleevely, with the idea of making it easier for research scientists to buy antibodies across the web. Milner was a postdoctoral researcher studying the newly discovered breast…